Robert Lerman
18Patents
4h-index
10Co-inventors
49Inventor score
Filing activity: Jun 18, 2003 → Apr 30, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7270835B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 29 | Expired |
| US7431948B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 27 | Expired |
| US8142819B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 14 | Expired |
| US7790205B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 6 | Expired |
| US8557306B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 4 | Active |
| US7807203B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | Human Necessities | 3 | Active |
| US7919125B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Active |
| US7811610B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | Human Necessities | 3 | Expired |
| US7794757B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Active |
| US7901714B2 | Treatment modalities for autoimmune diseases | Human Necessities | 3 | Active |
| US7820206B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Active |
| US7722903B2 | Modulation of inflammation by hops fractions and derivatives | Human Necessities | 3 | Expired |
| US7815944B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity | Human Necessities | 3 | Active |
| US7718198B2 | Treatment modalities for autoimmune diseases | Human Necessities | 3 | Expired |
| US7666449B2 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | Human Necessities | 3 | Active |
| US8257754B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 1 | Active |
| US8486457B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 0 | Active |
| US8168234B2 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.